{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:08:43Z","timestamp":1793837323857,"version":"4.6.1"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.semarthrit.2025.152828","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T17:12:21Z","timestamp":1757437941000},"page":"152828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["2025 Consensus-based recommendations for the referral, diagnosis, monitoring, and management of axial spondyloarthritis in the Arabian Gulf countries"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5875-4663","authenticated-orcid":false,"given":"Khalid A.","family":"Alnaqbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0328-4489","authenticated-orcid":false,"given":"Ghaydaa","family":"Aldabie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8529-4754","authenticated-orcid":false,"given":"Ahmad Al","family":"Enizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4754-2028","authenticated-orcid":false,"given":"Saadeya","family":"Abdulkarim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5021-7668","authenticated-orcid":false,"given":"Eman","family":"Satti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4824-4329","authenticated-orcid":false,"given":"Talal Al","family":"Lawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5617-5008","authenticated-orcid":false,"given":"Mohamed","family":"Bedaiwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4537-6015","authenticated-orcid":false,"given":"Denis","family":"Poddubnyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.semarthrit.2025.152828_bib0001","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/acr2.11555","article-title":"Human leukocyte antigen B27-negative axial spondyloarthritis: what do we know?","volume":"5","author":"Deodhar","year":"2023","journal-title":"ACR Open Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152828_bib0002","first-page":"2142","article-title":"Axial spondyloarthritis: one year in review 2023","volume":"41","author":"Fattorini","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152828_bib0003","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/1756-185X.13961","article-title":"The treatment journey for patients with axial spondyloarthritis in North Africa and the Middle East: from diagnosis to management","volume":"23","author":"El Zorkany","year":"2020","journal-title":"Int J Rheum Dis"},{"issue":"16","key":"10.1016\/j.semarthrit.2025.152828_bib0004","first-page":"5241","article-title":"A cross-sectional study on clinical characteristics of Saudi axial spondylarthritis: preliminary results","volume":"25","author":"Bedaiwi","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12891-017-1639-5","article-title":"HLA-B27 antigen in Middle Eastern and Arab countries: systematic review of the strength of association with axial spondyloarthritis and methodological gaps","volume":"18","author":"Ziade","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152828_bib0006","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/rheumatology\/keab901","article-title":"Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results","volume":"61","author":"Poddubnyy","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152828_bib0007","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152828_bib0008","first-page":"85","article-title":"Criteria of the classification of spondylarthropathies","volume":"57","author":"Amor","year":"1990","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152828_bib0009","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152828_bib0010","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152828_bib0011","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.2003.011247","article-title":"How to diagnose axial spondyloarthritis early","volume":"63","author":"Rudwaleit","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0012","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152828_bib0013","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/1756-185X.13510","article-title":"2018 APLAR axial spondyloarthritis treatment recommendations","volume":"22","author":"Tam","year":"2019","journal-title":"Int J Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152828_bib0014","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41584-023-01034-z","article-title":"Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis","volume":"19","author":"Bautista-Molano","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152828_bib0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3899\/jrheum.141001","article-title":"2014 Update of the Canadian Rheumatology Association\/Spondyloarthritis Research Consortium of Canada treatment recommendations for the management of spondyloarthritis. Part II: specific management recommendations","volume":"42","author":"Rohekar","year":"2015","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152828_bib0016","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/art.41042","article-title":"2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"71","author":"Ward","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152828_bib0017","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1123\/jpah.2022-0484","article-title":"Physical activity research in the Gulf Cooperation Council countries: progress made but work still to do","volume":"19","author":"HM","year":"2022","journal-title":"J Phys Act Health"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152828_bib0018","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/1756-185X.13487","article-title":"HLA-B27 prevalence in axial spondyloarthritis patients and in blood donors in a Lebanese population: results from a nationwide study","volume":"22","author":"Ziade","year":"2019","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152828_bib0019","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10067-021-06019-5","article-title":"Expert recommendations on early diagnosis and referral of axial spondyloarthritis in the Kingdom of Saudi Arabia","volume":"41","author":"Al Rayes","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"null","key":"10.1016\/j.semarthrit.2025.152828_bib0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/OARRR.S246246","article-title":"Recommendation for the management of spondyloarthritis patients in Kuwait","volume":"12","author":"Ali","year":"2020","journal-title":"Open Access Rheumatol: Res Rev"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0021","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/annrheumdis-2014-206350","article-title":"2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations","volume":"74","author":"van der Heijde","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0022","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152828_bib0023","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/0300060515611536","article-title":"Challenges of diagnosis and management of axial spondyloarthritis in North Africa and the Middle East: an expert consensus","volume":"44","author":"Hammoudeh","year":"2016","journal-title":"J Int Med Res"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152828_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2023.105579","article-title":"What is the best referral strategy for axial spondyloarthritis? A prospective multicenter study in patients with suspicious chronic low back pain","volume":"90","author":"Ziade","year":"2023","journal-title":"Jt Bone Spine"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000389","article-title":"Evaluation of multiple referral strategies for axial spondyloarthritis in the SPondyloArthritis caught early (SPACE) cohort","volume":"3","author":"Abawi","year":"2017","journal-title":"RMD Open"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152828_bib0026","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1093\/rheumatology\/keaa212","article-title":"Early recognition of patients with axial spondyloarthritis\u2014Evaluation of referral strategies in primary care","volume":"59","author":"Baraliakos","year":"2020","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152828_bib0027","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/annrheumdis-2014-207151","article-title":"Assessment of SpondyloArthritis international S. Development of an ASAS-endorsed recommendation for the early referral of patients with a suspicion of axial spondyloarthritis","volume":"74","author":"Poddubnyy","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152828_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131963","article-title":"External validation of a referral rule for axial spondyloarthritis in primary care patients with chronic low back pain","volume":"10","author":"van Hoeven","year":"2015","journal-title":"PLOS ONE"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152828_bib0029","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nrrheum.2012.39","article-title":"Referral strategies for early diagnosis of axial spondyloarthritis","volume":"8","author":"Rudwaleit","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152828_bib0030","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.mayocp.2020.02.007","article-title":"Recognizing axial spondyloarthritis: A guide for primary care","volume":"95","author":"Magrey","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152828_bib0031","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.rdc.2012.08.002","article-title":"Classification, diagnosis, and referral of patients with axial spondyloarthritis","volume":"38","author":"Braun","year":"2012","journal-title":"Rheum Dis Clin"},{"issue":"Suppl4","key":"10.1016\/j.semarthrit.2025.152828_bib0032","doi-asserted-by":"crossref","first-page":"iv6","DOI":"10.1093\/rheumatology\/keaa250","article-title":"Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis","volume":"59","author":"Poddubnyy","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0033","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002898","article-title":"Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study","volume":"9","author":"van der Togt","year":"2023","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0034","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pec.2011.02.004","article-title":"Patient preferences for shared decisions: A systematic review","volume":"86","author":"Chewning","year":"2012","journal-title":"Patient Educ Couns"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152828_bib0035","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s40744-023-00585-7","article-title":"Patients' needs concerning patient education in axial spondyloarthritis: A qualitative study","volume":"10","author":"van der Kraan","year":"2023","journal-title":"Rheumatol Ther"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152828_bib0036","first-page":"975","article-title":"Burden of illness associated with non-radiographic axial spondyloarthritis: A multiperspective European cross-sectional observational study","volume":"34","author":"Sieper","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0037","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/acr.22908","article-title":"Disease activity as a major determinant of quality of life and physical function in patients with early axial spondyloarthritis","volume":"69","author":"Fern\u00e1ndez-Carballido","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152828_bib0038","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/art.21330","article-title":"Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy","volume":"53","author":"Davis","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152828_bib0039","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00296-009-1328-2","article-title":"Quality of life in patients with ankylosing spondylitis: relationships with spinal mobility, disease activity and functional status","volume":"31","author":"Ozdemir","year":"2011","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152828_bib0040","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10067-005-1150-5","article-title":"Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients","volume":"25","author":"Ozg\u00fcl","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152828_bib0041","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1136\/annrheumdis-2014-205178","article-title":"Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort","volume":"73","author":"Ramiro","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152828_bib0042","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/ard.2008.091793","article-title":"Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine","volume":"68","author":"Landew\u00e9","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152828_bib0043","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1136\/annrheumdis-2016-209209","article-title":"High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort","volume":"75","author":"Poddubnyy","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0044","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/ard-2022-223297","article-title":"Efficacy and safety of non-pharmacological and non-biological interventions: A systematic literature review informing the 2022 update of the ASAS\/EULAR recommendations for the management of axial spondyloarthritis","volume":"82","author":"Ortolan","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/1756-185X.13752","article-title":"Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis","volume":"23","author":"Wei","year":"2020","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0046","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13075-016-1093-z","article-title":"Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: A meta-analysis","volume":"18","author":"de Winter","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0047","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","article-title":"Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: A systematic review and meta-analysis","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"Supplement_4","key":"10.1016\/j.semarthrit.2025.152828_bib0048","doi-asserted-by":"crossref","first-page":"iv47","DOI":"10.1093\/rheumatology\/keaa246","article-title":"Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis","volume":"59","author":"Zhao","year":"2020","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152828_bib0049","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/rheumatology\/kez119","article-title":"Comorbidity burden in axial spondyloarthritis: A cluster analysis","volume":"58","author":"Zhao","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0050","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20966123","article-title":"Comorbid pain in axial spondyloarthritis, including fibromyalgia","volume":"12","author":"L\u00f3pez-Medina","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0051","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40674-017-0061-3","article-title":"Comorbidities in spondyloarthritis","volume":"3","author":"Danve","year":"2017","journal-title":"Curr Treat Options Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152828_bib0052","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s10067-012-2058-5","article-title":"Early diagnosis and treatment of ankylosing spondylitis in Africa and the Middle East","volume":"31","author":"Rachid","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0053","article-title":"Characteristics of ankylosing spondylitis patients living in Qatar","volume":"39","author":"Alam","year":"2016","journal-title":"Egypt Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0054","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1744-313X.1996.tb00265.x","article-title":"Association of MHC class I with spondyloarthropathies in Kuwait","volume":"23","author":"Alharbi","year":"1996","journal-title":"Eur J Immunogenet"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152828_bib0055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10067-005-1162-1","article-title":"Ankylosing spondylitis and undifferentiated spondyloarthritis in Kuwait: a comparison between Arabs and South Asians","volume":"25","author":"Uppal","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0056","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1136\/annrheumdis-2024-eular.305","article-title":"AB0935 Comparing clinical characteristics of patients with peripheral and axial spondyloarthropathies: an analysis of the Kuwait SpA Registry","volume":"83","author":"Abotaiban","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0057","article-title":"Diagnostic delay in patients with Axial spondylarthritis, review of clinical and radiological data - United Arab Emirates (UAE) experience","volume":"19","author":"Khan","year":"2024","journal-title":"Int J Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152828_bib0058","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3109\/0886022X.2014.937672","article-title":"Association between Human leukocyte antigens (HLA-A, -B, and -DR) and end-stage renal disease in Kuwaiti patients awaiting transplantation","volume":"36","author":"Mosaad","year":"2014","journal-title":"Ren Fail"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0059","first-page":"383","article-title":"Clinically important human leukocyte antigen (HLA) alleles among the Bahraini population","volume":"43","author":"Farid","year":"2021","journal-title":"Bahrain Med Bull"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152828_bib0060","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s10067-017-3655-0","article-title":"Prevalence of HLA-B27 in the general population and in patients with axial spondyloarthritis in Saudi Arabia","volume":"36","author":"Omair","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152828_bib0061","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5144\/0256-4947.1999.193","article-title":"Histocompatibility antigens in Omanis: comparison with other Gulf populations and implications for disease association","volume":"19","author":"White","year":"1999","journal-title":"Ann Saudi Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152828_bib0062","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/03009749509100878","article-title":"HLA-B27 in healthy adults in UAE. An extremely low prevalence in Emirian Arabs","volume":"24","author":"al-Attia","year":"1995","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0063","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13075-017-1335-8","article-title":"Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts","volume":"19","author":"Ez-Zaitouni","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152828_bib0064","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001418","article-title":"Chronic back pain in first-degree relatives (FDRs) of patients with ankylosing spondylitis: predictive value of HLA-B27 and persistence of inflammatory back pain over time","volume":"6","author":"Doughem","year":"2020","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0065","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-002174","article-title":"Geographical prevalence of family history in patients with axial spondyloarthritis and its association with HLA-B27 in the ASAS-PerSpA study","volume":"8","author":"Boel","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(25)00108-0","article-title":"The imaging crisis in axial spondyloarthritis","author":"Diekhoff","year":"2025","journal-title":"Lancet Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152828_bib0067","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-004044","article-title":"Diagnostic accuracy in axial spondyloarthritis: a systematic evaluation of the role of clinical information in the interpretation of sacroiliac joint imaging","volume":"10","author":"Pohlner","year":"2024","journal-title":"RMD Open"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152828_bib0068","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/ard-2024-226280","article-title":"Clinical information on imaging referrals for suspected or known axial spondyloarthritis: recommendations from the Assessment of Spondyloarthritis International Society (ASAS)","volume":"83","author":"Diekhoff","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152828_bib0069","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1055\/s-0035-1564696","article-title":"Recommendations of the ESSR Arthritis Subcommittee for the use of magnetic resonance imaging in musculoskeletal rheumatic diseases","volume":"19","author":"Sudo\u0142-Szopi\u0144ska","year":"2015","journal-title":"Semin Musculoskelet Radiol"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152828_bib0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/annrheumdis-2021-220136","article-title":"Choose wisely: imaging for diagnosis of axial spondyloarthritis","volume":"81","author":"Diekhoff","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152828_bib0071","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3899\/jrheum.130141","article-title":"Magnetic resonance imaging compared to conventional radiographs for detection of chronic structural changes in sacroiliac joints in axial spondyloarthritis","volume":"40","author":"Poddubnyy","year":"2013","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152828_bib0072","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/art.38738","article-title":"Agreement between clinical practice and trained central reading in reading of sacroiliac joints on plain pelvic radiographs. Results from the DESIR cohort","volume":"66","author":"van den Berg","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0073","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3389\/fimmu.2020.00936","article-title":"Spine and sacroiliac joints lesions on magnetic resonance imaging in early axial-spondyloarthritis during 24-months follow-up (Italian arm of SPACE study)","volume":"11","author":"Lorenzin","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152828_bib0074","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/art.38283","article-title":"Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis","volume":"66","author":"van der Heijde","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152828_bib0075","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/art.10883","article-title":"Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system","volume":"48","author":"Braun","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152828_bib0076","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4081\/reumatismo.2016.885","article-title":"Spine and sacroiliac joints on magnetic resonance imaging in patients with early axial spondyloarthritis: prevalence of lesions and association with clinical and disease activity indices from the Italian group of the SPACE study","volume":"68","author":"Lorenzin","year":"2016","journal-title":"Reumatismo"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152828_bib0077","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/rheumatology\/kep427","article-title":"Group obotLS. The evidence for whole-spine MRI in the assessment of axial spondyloarthropathy","volume":"49","author":"Bennett","year":"2010","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152828_bib0078","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.crad.2019.01.008","article-title":"Do we need to perform MRI of the whole spine in addition to MRI of the sacroiliac joints in suspected spondyloarthropathy?","volume":"74","author":"Naqvi","year":"2019","journal-title":"Clin Radiol"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152828_bib0079","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.2214\/AJR.17.19404","article-title":"Postpartum bone marrow edema at the sacroiliac joints may mimic sacroiliitis of axial spondyloarthritis on MRI","volume":"211","author":"Agten","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152828_bib0080","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/art.42457","article-title":"Evolution of magnetic resonance imaging lesions at the sacroiliac joints during and after pregnancy by serial magnetic resonance imaging from gestational week twenty to twelve months postpartum","volume":"75","author":"Kiil","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152828_bib0081","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/annrheumdis-2020-217095","article-title":"High prevalence of spondyloarthritis-like MRI lesions in postpartum women: A prospective analysis in relation to maternal, child and birth characteristics","volume":"79","author":"Renson","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152828_bib0082","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00296-020-04582-9","article-title":"Osteitis condensans ilii: current knowledge and diagnostic approach","volume":"40","author":"Parperis","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0083","doi-asserted-by":"crossref","DOI":"10.5334\/jbr-btr.1385","article-title":"Pelvic musculoskeletal disorders related to pregnancy","author":"Riahi","year":"2017","journal-title":"J Belg Soc Radiol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152828_bib0084","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2214\/AJR.16.16774","article-title":"The value of the T2-weighted multipoint dixon sequence in MRI of sacroiliac joints for the diagnosis of active and chronic sacroiliitis","volume":"208","author":"\u00d6zgen","year":"2017","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152828_bib0085","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1093\/rheumatology\/keaa175","article-title":"Clinical and imaging characteristics of osteitis condensans ilii as compared with axial spondyloarthritis","volume":"59","author":"Poddubnyy","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152828_bib0086","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/1756-185X.13991","article-title":"Recognition of spondyloarthritis lesions on magnetic resonance imaging: results of an educational intervention","volume":"23","author":"Garcia Salinas","year":"2020","journal-title":"Int J Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152828_bib0087","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/acr.20312","article-title":"Assessment of structural lesions in sacroiliac joints enhances diagnostic utility of magnetic resonance imaging in early spondylarthritis","volume":"62","author":"Weber","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0088","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2021-222020","article-title":"2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases","volume":"82","author":"Gwinnutt","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152828_bib0089","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/annrheumdis-2021-220249","article-title":"2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis","volume":"80","author":"Nikiphorou","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152828_bib0090","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/annrheumdis-2014-206807","article-title":"EULAR recommendations for patient education for people with inflammatory arthritis","volume":"74","author":"Zangi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0091","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0115733971368196250117105119","article-title":"Infection screening and vaccination of adult and pediatric patients with autoimmune inflammatory rheumatic diseases: an Emirati delphi consensus","volume":"21","author":"Almarzooqi","year":"2025","journal-title":"Curr Rheumatol Rev"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152828_bib0092","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/ard-2022-223335","article-title":"2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases","volume":"82","author":"Fragoulis","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152828_bib0093","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/14740338.2019.1612872","article-title":"Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice","volume":"18","author":"Cantini","year":"2019","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0094","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/joim.13218","article-title":"Tuberculosis in patients with systemic lupus erythematosus - A 37-year longitudinal survey-based study","volume":"290","author":"Xiao","year":"2021","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5606\/ArchRheumatol.2018.6833","article-title":"Turkish League Against Rheumatism consensus report: recommendations for management of axial spondyloarthritis","volume":"33","author":"Bodur","year":"2018","journal-title":"Arch Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152828_bib0096","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s40259-023-00642-1","article-title":"Consensus-based overarching principles and recommendations on the use of biosimilars in the treatment of inflammatory arthritis in the Gulf region","volume":"38","author":"Alnaqbi","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0097","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.22577.1","article-title":"Recent advances in managing axial spondyloarthritis","volume":"9","author":"Agrawal","year":"2020","journal-title":"F1000Res"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2025.152828_bib0098","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/annrheumdis-2022-eular.4703","article-title":"POS0950 Long-term follow-up of starting and switching from original adalimumab to adalimumab biosimilar: real-world data in axial spondyloarthritis","volume":"81","author":"Pinto","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152828_bib0099","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3899\/jrheum.170224","article-title":"Comparative efficacy of tumor necrosis factor-\u03b1 inhibitors in ankylosing spondylitis: A systematic review and bayesian network meta-analysis","volume":"45","author":"Wang","year":"2018","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152828_bib0100","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1136\/annrheumdis-2012-203091","article-title":"A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study","volume":"72","author":"Park","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152828_bib0101","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s00296-009-1157-3","article-title":"A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis","volume":"30","author":"Giardina","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0102","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13075-016-0930-4","article-title":"Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study","volume":"18","author":"Park","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0103","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S2665-9913(19)30013-X","article-title":"IBI303, a biosimilar to adalimumab, for the treatment of patients with ankylosing spondylitis in China: A randomised, double-blind, phase 3 equivalence trial","volume":"1","author":"Xu","year":"2019","journal-title":"Lancet Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152828_bib0104","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s40259-020-00408-z","article-title":"Comparison of the efficacy and safety of adalimumab (Humira) and the adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis: A multicenter, randomized, double-blind, parallel, phase III clinical trial","volume":"34","author":"Su","year":"2020","journal-title":"BioDrugs"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152828_bib0105","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s12325-018-0742-9","article-title":"Non-medical switching from originator tumor necrosis factor inhibitors to their biosimilars: systematic review of randomized controlled trials and real-world studies","volume":"35","author":"Numan","year":"2018","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0106","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apt.14997","article-title":"Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximab","volume":"49","author":"Feagan","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0107","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3389\/fphar.2019.01010","article-title":"Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving infliximab: A systematic review in the context of decision-making from a Latin-American country","volume":"10","author":"Mezones-Holguin","year":"2019","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0108","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s43441-024-00716-4","article-title":"Expert consensus recommendations on a biosimilars value framework for the Gulf Cooperation Council countries","volume":"59","author":"Alnaqbi","year":"2025","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0109","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2021.11.009","article-title":"The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems","volume":"52","author":"Kvien","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0110","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.2147\/DDDT.S115099","article-title":"Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability","volume":"10","author":"Bandinelli","year":"2016","journal-title":"Drug Des Devel Ther."},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0111","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/annrheumdis-2012-203055","article-title":"Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trial","volume":"73","author":"Haibel","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"01","key":"10.1016\/j.semarthrit.2025.152828_bib0112","doi-asserted-by":"crossref","DOI":"10.4172\/2167-7921.1000266","article-title":"Intravenous glucocorticoid pulse therapy in active, nsaid refractory axial ankylosing spondylitis: A retrospective analysis spanning 12 months","volume":"07","author":"Rihl","year":"2018","journal-title":"J Arthritis"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152828_bib0113","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006957","article-title":"A long-term, observational cohort study on the safety of low-dose glucocorticoids in ankylosing spondylitis: adverse events and effects on bone mineral density, blood lipid and glucose levels and body mass index","volume":"5","author":"Zhang","year":"2015","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152828_bib0114","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/rheumatology\/keaa685","article-title":"Efficacy of a step-down regimen of oral prednisolone in axial spondyloarthritis: result of a double-blind randomized controlled trial (COBRA-AS Study)","volume":"60","author":"Mishra","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152828_bib0115","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00296-005-0008-0","article-title":"Magnetic resonance imaging guided corticosteroid injection of sacroiliac joints in patients with spondylarthropathy. Are multiple injections more beneficial?","volume":"26","author":"G\u00fcnaydin","year":"2006","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0116","first-page":"88","article-title":"Periarticular corticosteroid treatment of the sacroiliac joint in patients with seronegative spondylarthropathy","volume":"17","author":"Luukkainen","year":"1999","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152828_bib0117","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/rheumatology\/35.8.767","article-title":"Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies: A double-blind study","volume":"35","author":"Maugars","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152828_bib0118","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/art.1780350512","article-title":"Corticosteroid injection of the sacroiliac joint in patients with seronegative spondylarthropathy","volume":"35","author":"Maugars","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152828_bib0119","first-page":"465","article-title":"A new technical contribution for ultrasound-guided injections of sacro-iliac joints","volume":"14","author":"Migliore","year":"2010","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0120","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/RHU.0000000000001584","article-title":"Efficacy and safety of intra-articular sacroiliac glucocorticoid injections in ankylosing spondylitis","volume":"28","author":"Nam","year":"2022","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152828_bib0121","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00004728-199607000-00002","article-title":"CT-guided intraarticular corticosteroid injection into the sacroiliac joints in patients with spondyloarthropathy: indication and follow-up with contrast-enhanced MRI","volume":"20","author":"Bollow","year":"1996","journal-title":"J Comput Assist Tomogr"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0122","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s42358-020-0116-2","article-title":"The Brazilian Society of Rheumatology guidelines for axial spondyloarthritis \u20132019","volume":"60","author":"Resende","year":"2020","journal-title":"Adv Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152828_bib0123","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1093\/rheumatology\/keab275","article-title":"Glucocorticoids in spondyloarthritis-systematic review and real-world analysis","volume":"60","author":"Dhir","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152828_bib0124","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00296-016-3440-4","article-title":"Ultrasound-guided retro-calcaneal bursa corticosteroid injection for refractory Achilles tendinitis in patients with seronegative spondyloarthropathy: efficacy and follow-up study","volume":"36","author":"Srivastava","year":"2016","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152828_bib0125","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3113\/FAI.2009.0661","article-title":"Glucocorticoid injections in lesions of the achilles tendon","volume":"30","author":"Metcalfe","year":"2009","journal-title":"Foot Ankle Int"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152828_bib0126","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.semarthrit.2020.08.011","article-title":"Pregnancy in axial spondyloarthropathy: A systematic review & meta-analysis","volume":"50","author":"Maguire","year":"2020","journal-title":"Sem Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152828_bib0127","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.semarthrit.2021.05.010","article-title":"Corrigendum to pregnancy in axial spondyloarthropathy: A systematic review & meta-analysis Seminars Arthritis Rheum","volume":"51","author":"Maguire","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152828_bib0128","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/annrheumdis-2015-207992","article-title":"Pregnancy outcomes in patients with ankylosing spondylitis: A nationwide register study","volume":"75","author":"Jakobsson","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0129","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.151993","article-title":"What to expect when women with axial spondyloarthritis are expecting: prevalence of complications of pregnancies in women with axial spondyloarthritis","volume":"54","author":"Maguire","year":"2022","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152828_bib0130","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152828_bib0131","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"G\u00f6testam Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152828_bib0132","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1093\/rheumatology\/keac551","article-title":"British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids","volume":"62","author":"Russell","year":"2022","journal-title":"Rheumatology."},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0133","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13075-017-1269-1","article-title":"Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients","volume":"19","author":"van den Brandt","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152828_bib0134","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/ard-2022-222641","article-title":"Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP)","volume":"81","author":"Meissner","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152828_bib0135","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/S2665-9913(23)00001-2","article-title":"Temporal trends in adverse pregnancy outcomes in axial spondyloarthritis in Sweden: A cohort study","volume":"5","author":"Morin","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152828_bib0136","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.5001\/omj.2022.69","article-title":"Predictors of not achieving remission or low disease activity in axial spondyloarthritis patients from middle eastern countries: A prospective, multicenter, real-world study","volume":"37","author":"Al-Saleh","year":"2022","journal-title":"Oman Med J"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152828_bib0137","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s10067-023-06655-z","article-title":"Cardiovascular risk in axial spondyloarthritis\u2014A systematic review","volume":"42","author":"Hintenberger","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0138","series-title":"Spondyloarthritis in over 16s: diagnosis and management","year":"2016"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152828_bib0139","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/annrheumdis-2015-208174","article-title":"Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study","volume":"75","author":"Molt\u00f3","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152828_bib0141","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1136\/ard-2023-225406","article-title":"Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis","volume":"83","author":"Kim","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0142","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/rheumatology\/kead684","article-title":"Risk of cardiovascular disease associated with long-term use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis","volume":"64","author":"Kim","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0143","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152477","article-title":"Impact of inflammation and anti-inflammatory therapies on the incidence of major cardiovascular events in patients with ankylosing spondylitis: A population-based study","volume":"67","author":"Shi","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0144","unstructured":"European Medical Agency. Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 24-27 October 2022 Available from: https:\/\/www.ema.europa.eu\/en\/news\/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-24-27-october-2022#:~:text=EMA's%20safety%20committee%20(PRAC)%20has,clots%2C%20cancer%20and%20serious%20infections."},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152828_bib0146","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1053\/j.gastro.2020.01.001","article-title":"Safety of Janus kinase inhibitors in patients with inflammatory bowel diseases or other immune-mediated diseases: A systematic review and meta-analysis","volume":"158","author":"Olivera","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152828_bib0147","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40744-020-00233-4","article-title":"Cardiovascular risk prediction in ankylosing spondylitis: from traditional scores to machine learning assessment","volume":"7","author":"Navarini","year":"2020","journal-title":"Rheumatol Ther"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152828_bib0148","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/annrheumdis-2021-221733","article-title":"EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome","volume":"81","author":"Drosos","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152828_bib0149","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","article-title":"American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"68","author":"Ward","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152828_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2022.105344","article-title":"2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis","volume":"89","author":"Wendling","year":"2022","journal-title":"Jt Bone Spine"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152828_bib0151","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4081\/reumatismo.2021.1367","article-title":"The Italian Society for Rheumatology recommendations for the management of axial spondyloarthritis","volume":"73","author":"Manara","year":"2021","journal-title":"Reumatismo"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152828_bib0152","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2014-206971","article-title":"EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice","volume":"74","author":"Mandl","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152828_bib0153","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/jbmr.2176","article-title":"Trabecular bone score: a noninvasive analytical method based upon the DXA image","volume":"29","author":"Silva","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152828_bib0154","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00198-014-2685-6","article-title":"TBS result is not affected by lumbar spine osteoarthritis","volume":"25","author":"Kolta","year":"2014","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152828_bib0155","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jbspin.2016.05.015","article-title":"Impact of lumbar syndesmophyte on bone health as assessed by bone density (BMD) and bone texture (TBS) in men with axial spondyloarthritis","volume":"84","author":"Wildberger","year":"2017","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0156","first-page":"1","article-title":"Registries in spondyloarthritis: what have we learned?","volume":"9","author":"Ziad\u00e9","year":"2017","journal-title":"MOJ Orthop Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0157","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13063-019-3272-0","article-title":"Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation","volume":"20","author":"Bingham","year":"2019","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0158","doi-asserted-by":"crossref","DOI":"10.2196\/15588","article-title":"Benefits and disadvantages of electronic patient-reported outcome measures: systematic review","volume":"3","author":"Meirte","year":"2020","journal-title":"JMIR Perioper Med"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152828_bib0159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253615","article-title":"Electronic patient-reported outcome measures using mobile health technology in rheumatology: A scoping review","volume":"16","author":"Shelton","year":"2021","journal-title":"PloS one"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152828_bib0160","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrrheum.2015.116","article-title":"Patient-reported outcomes in core domain sets for rheumatic diseases","volume":"11","author":"van Tuyl","year":"2015","journal-title":"Nature Reviews Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0161","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-002106","article-title":"Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in France","volume":"8","author":"Dougados","year":"2022","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152828_bib0162","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000302","article-title":"Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools","volume":"2","author":"van Riel","year":"2016","journal-title":"RMD Open"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152828_bib0163","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00296-024-05673-7","article-title":"Patients with axial spondyloarthritis reported willingness to use remote care and showed high adherence to electronic patient-reported outcome measures: an 18-month observational study","volume":"44","author":"Thomassen","year":"2024","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0164","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12969-021-00551-z","article-title":"Electronic forms for patient reported outcome measures (PROMs) are an effective, time-efficient, and cost-minimizing alternative to paper forms","volume":"19","author":"Yu","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.31138\/mjr.011123.fst","article-title":"From sand to excellence: A deep dive into Abu Dhabi's rheumatology landscape","volume":"35","author":"Alnaqbi","year":"2024","journal-title":"Mediterr J Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152828_bib0166","doi-asserted-by":"crossref","unstructured":"Alnaqbi K.A., Alaswad M., Al Araimi T., Mahmoud A.A.A., Al Emadi S., Al Rayyes H., et al. Challenges of referral, diagnosis and management of axial spondyloarthritis in the Gulf countries: insights from a cross-sectional survey to rheumatologists. Rheumatol Int. 2025 Aug 7;45(8):186. DOI: 10.1007\/s00296-025-05937-w.","DOI":"10.1007\/s00296-025-05937-w"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152828_bib0167","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: A guide to assess spondyloarthritis","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152828_bib0168","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1136\/ard-2024-225882","article-title":"Development of international consensus on a standardised image acquisition protocol for diagnostic evaluation of the sacroiliac joints by MRI: an ASAS-SPARTAN collaboration","volume":"83","author":"Lambert","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152828_bib0169","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1136\/annrheumdis-2014-205432","article-title":"Classification of axial SpA based on positive imaging (radiographs and\/or MRI of the sacroiliac joints) by local rheumatologists or radiologists versus central trained readers in the DESIR cohort","volume":"74","author":"van den Berg","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152828_bib0170","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s10067-025-07388-x","article-title":"Patient perspectives on rheumatic and musculoskeletal diseases: insights from a large-scale survey","volume":"44","author":"Alnaqbi","year":"2025","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152828_bib0171","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s44197-023-00097-1","article-title":"Progress of the Gulf Cooperation Council (GCC) countries towards achieving the 95-95-95 UNAIDS targets: A review","volume":"13","author":"Awaidy","year":"2023","journal-title":"J Epidemiol Glob Health"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0172","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5144\/0256-4947.2021.8","article-title":"Seropositivity of syphilis among individuals screened in a tertiary hospital in the Eastern Province of Saudi Arabia","volume":"41","author":"Wanni","year":"2021","journal-title":"Ann Saudi Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152828_bib0173","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1186\/s12879-024-10153-1","article-title":"Sexually transmitted infections in the middle east and North Africa: comprehensive systematic review and meta-analysis","volume":"24","author":"Obeid","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152828_bib0174","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-083810","article-title":"Prevalence of syphilis infection among migrant workers in Qatar: A nationwide cross-sectional survey","volume":"14","author":"Nasrallah","year":"2024","journal-title":"BMJ Open"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225001994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225001994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:54:01Z","timestamp":1765979641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225001994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":173,"alternative-id":["S0049017225001994"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152828","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2025 Consensus-based recommendations for the referral, diagnosis, monitoring, and management of axial spondyloarthritis in the Arabian Gulf countries","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152828"}}